6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
Hahn JY, Song YB, SMART-DATE investigators et al.
KEYWORDS
6-month versus 12-month DAPT; DES; ACS; PCI